Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 31, 2014
Pharmacy Choice - Pharmaceutical News - LatisseDoctor.com Reports on Allergan's Continued Work on Hair Loss Product Despite Delays - October 31, 2014

Pharmacy News Article

 3/7/14 - LatisseDoctor.com Reports on Allergan's Continued Work on Hair Loss Product Despite Delays

(PRWEB) March 07, 2014

Allergan's move to take part in the massive hair loss market is the subject of the latest LatisseDoctor.com report. The current lineup of Allergan products include JUV?DERM, BOTOX, VIVITE, SkinMedica, NATRELLE breast implants and LATISSE. It is this last product that was the launching point for Allergan's attempt to enter the hair loss market reports LatisseDoctor.com. The active ingredient, bimatoprost was found to improve eyelash growth, and Allergan researchers are hoping it can do the same for hair.

The LatisseDoctor.com report also discusses the size of market itself and the opportunity that it poses for Allergan to increase its revenue by hundreds of millions of dollars. A hair loss product would open up an entirely new demographic for Allergan that includes millions of men in the U.S. alone. LatisseDoctor.com reports that early estimates suggest Allergan could generate upwards of $500 million a year by 2020 if they were able to get a hair loss product approved by the FDA.

Allergan started the FDA approval process with a first phase trial study in 2010. Despite not having FDA approval yet, LatisseDoctor.com reports that some doctors have already been using LATISSE off-label to treat male pattern baldness in patients that have allergic reactions to minoxidil-based products. Though Allergan's bimatoprost hair loss product has shown promise, Allergan made the decision last year to put the third and final FDA trial phase on hold.

Given the disappointment with Allergan's decision to put the bimatoprost hair loss product on hold it's no surprise that the company still plans to move forward with research. David Pyott, Allergan's Chief Executive, assured investors that the company would do more studies on the hair loss product before conducting late-stage FDA trials. Earlier this year Allergan announced they would be boosting research spending to $1 billion, which is an indicator that the company is still invested in creating a new hair loss product even though FDA trials have stalled.

To learn more about LATISSE products or to see the full report on Allergan's move into the hair loss market, please visit: LatisseDoctor.com

About LatisseDoctor.com:

LatisseDoctor.com was created to provide a faster, less expensive and more convenient way to purchase authentic LATISSE products. LatisseDoctor.com is able to accomplish this by having patients fill in a medical history form which a registered physician will review. This allows customers to purchase LATISSE online without visiting a physician, saving customers time and money. LatisseDoctor.com is a subsidiary of Allied Medical & Diagnostic Services, LLC.

Read the full story at http://www.prweb.com/releases/2014/03/prweb11635324.htm



(c) 2014 PRWEB.COM Newswire

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Nov 04: Type II Diabetes: Case Studies and Management Options
Nov 05: Introduction to Emergency Preparedness
Nov 09: Weight Loss Management: Medical, Surgical & Alternative Therapies
Nov 11: Acne Vulgaris: Comprehensive Pharmaceutical Care
Nov 12: Men's Health Issues: Urological Concerns
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415